Literature DB >> 26754918

Transcriptomic Changes in Osteoblasts Following Endothelial Cell-Cocultivation Suggest a Role of Extracellular Matrix in Cellular Interaction.

Florian M Lampert1, Filip Simunovic1, Günter Finkenzeller1, Dietmar Pfeifer2, G Björn Stark1, Oscar Winninger1, Dominik Steiner3.   

Abstract

Vascularization is important for bone development, fracture healing and engineering of artificial bone tissue. In the context of bone tissue engineering, it was shown that coimplantation of human primary umbilical vein endothelial cells (HUVECs) and human osteoblasts (hOBs) results in the formation of functional blood vessels and enhanced bone regeneration. Implanted endothelial cells do not only contribute to blood vessel formation, but also support proliferation, cell survival and osteogenic differentiation of coimplanted hOBs. These effects are partially mediated by direct heterotypic cell contacts. In a previous report we could show that cocultivated hOBs strongly increase the expression of genes involved in extracellular matrix (ECM) formation in HUVECs, suggesting that ECM may be involved in the intercellular communication between hOBs and HUVECs. The present study aimed at investigating whether comparable changes occur in hOBs. We therefore performed a microarray analysis of hOBs cultivated in direct contact with HUVECs, revealing 1,004 differentially expressed genes. The differentially expressed genes could be assigned to the functional clusters ECM, proliferation, apoptosis and osteogenic differentiation. The microarray data could be confirmed by performing quantitative real time RT-PCR on selected genes. Furthermore, we could show that the ECM produced by HUVECs increased the expression of the osteogenic differentiation marker alkaline phosphatase (ALP) in hOBs. In summary, our data demonstrate that HUVECs provoke complex changes in gene expression patterns in cocultivated hOBs and that ECM plays and important role in this interaction. J. Cell. Biochem. 117: 1869-1879, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  APOPTOSIS; BONE TISSUE ENGINEERING; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; HUMAN OSTEOBLASTS; OSTEOGENIC DIFFERENTIATION; PROLIFERATION

Mesh:

Year:  2016        PMID: 26754918     DOI: 10.1002/jcb.25486

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  Fabrication of a bio-instructive scaffold conferred with a favorable microenvironment allowing for superior implant osseointegration and accelerated in situ vascularized bone regeneration via type H vessel formation.

Authors:  Yijun He; Wenhao Wang; Shaozhang Lin; Yixi Yang; Lizhi Song; Yihan Jing; Lihao Chen; Zaopeng He; Wei Li; Ao Xiong; Kelvin W K Yeung; Qi Zhao; Yuan Jiang; Zijie Li; Guoxian Pei; Zhi-Yong Zhang
Journal:  Bioact Mater       Date:  2021-08-12

Review 2.  Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration.

Authors:  Cyril Bouland; Pierre Philippart; Didier Dequanter; Florent Corrillon; Isabelle Loeb; Dominique Bron; Laurence Lagneaux; Nathalie Meuleman
Journal:  Front Cell Dev Biol       Date:  2021-05-13

3.  Bone tissue engineering using adipose-derived stem cells and endothelial cells: Effects of the cell ratio.

Authors:  Hilkea Mutschall; Sophie Winkler; Volker Weisbach; Andreas Arkudas; Raymund E Horch; Dominik Steiner
Journal:  J Cell Mol Med       Date:  2020-05-12       Impact factor: 5.310

4.  A novel method to improve the osteogenesis capacity of hUCMSCs with dual-directional pre-induction under screened co-culture conditions.

Authors:  Qiong Rong; Shuyi Li; Yang Zhou; Yuanming Geng; Shangbin Liu; Wanqiu Wu; Tim Forouzanfar; Gang Wu; Zhiyong Zhang; Miao Zhou
Journal:  Cell Prolif       Date:  2019-12-09       Impact factor: 6.831

Review 5.  Human Umbilical Vein Endothelial Cells (HUVECs) Co-Culture with Osteogenic Cells: From Molecular Communication to Engineering Prevascularised Bone Grafts.

Authors:  Ievgeniia Kocherova; Artur Bryja; Paul Mozdziak; Ana Angelova Volponi; Marta Dyszkiewicz-Konwińska; Hanna Piotrowska-Kempisty; Paweł Antosik; Dorota Bukowska; Małgorzata Bruska; Dariusz Iżycki; Maciej Zabel; Michał Nowicki; Bartosz Kempisty
Journal:  J Clin Med       Date:  2019-10-03       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.